$VEEV
Veeva Systems Inc.
Cloud software platform for the global life sciences and pharmaceutical industry.
VEEV key facts as of November 14, 2026
- Latest AI research report
- VEEV Stock: Growth, Valuation and Key Risks (as of November 14, 2026)
- StockAlpha report sentiment
- Neutral (as of November 14, 2026)
- Analyst consensus
- Strong Buy (7 Strong Buy, 13 Buy, 8 Hold, 1 Sell, 0 Strong Sell) (as of November 1, 2026)
- Analyst price target
- $306.67 mean (range $165.00 to $400.00) (as of November 17, 2026)
- Sector
- Healthcare
Analysis from Nov 13, 2026
VEEV Stock: Growth, Valuation and Key Risks
Veeva combines recurring life-sciences software revenue with strong cash generation and recent earnings growth. At $301.53 as of Friday, November 13, the shares sit near the supplied analyst mean target, while premium valuation and the December 3 earnings report remain important considerations.
Previous Reports
VEEV FAQ
What is StockAlpha's latest view on VEEV?
StockAlpha's latest AI research report on Veeva Systems Inc. (VEEV), "VEEV Stock: Growth, Valuation and Key Risks", was published on November 14, 2026 and rates the overall sentiment as neutral. Veeva combines recurring life-sciences software revenue with strong cash generation and recent earnings growth. At $301.53 as of Friday, November 13, the shares sit near the supplied analyst mean target, while premium valuation and the December 3 earnings report remain important considerations.
When was the VEEV research last updated?
The most recent VEEV report was published on November 14, 2026.
What do analysts expect for VEEV?
As of November 1, 2026, the analyst consensus on VEEV is Strong Buy (7 Strong Buy, 13 Buy, 8 Hold, 1 Sell, 0 Strong Sell). As of November 17, 2026, the analyst price target is $306.67 mean (range $165.00 to $400.00).
Is this VEEV research investment advice?
No. StockAlpha.ai research is AI-generated analysis for informational purposes only and is not investment advice. Analyst figures are third-party data. Do your own research before making investment decisions.
Keep exploring
- draft Veeva Systems into a free practice contest: How to put the stock you just researched into a contest lineup at no real-money risk
- the healthcare sector brief for context on Veeva Systems's peers: Today's sector-level news and moves around the stock